- Home
- CNEY vs ACON Comparison
CNEY vs ACON Comparison
Compare CNEY & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNEY
- ACON
- Stock Information
- Founded
- CNEY 2018
- ACON 2008
- Country
- CNEY China
- ACON United States
- Employees
- CNEY N/A
- ACON N/A
- Industry
- CNEY Major Chemicals
- ACON Retail: Computer Software & Peripheral Equipment
- Sector
- CNEY Industrials
- ACON Technology
- Exchange
- CNEY Nasdaq
- ACON Nasdaq
- Market Cap
- CNEY 1.0M
- ACON 977.9K
- IPO Year
- CNEY 2021
- ACON 2022
- Fundamental
- Price
- CNEY $0.28
- ACON $0.04
- Analyst Decision
- CNEY
- ACON Buy
- Analyst Count
- CNEY 0
- ACON 2
- Target Price
- CNEY N/A
- ACON $1.30
- AVG Volume (30 Days)
- CNEY 1.6M
- ACON 48.1M
- Earning Date
- CNEY 01-01-0001
- ACON 11-14-2024
- Dividend Yield
- CNEY N/A
- ACON N/A
- EPS Growth
- CNEY N/A
- ACON N/A
- EPS
- CNEY N/A
- ACON N/A
- Revenue
- CNEY $66,509,375.00
- ACON $49,289.00
- Revenue This Year
- CNEY N/A
- ACON N/A
- Revenue Next Year
- CNEY N/A
- ACON $186.36
- P/E Ratio
- CNEY N/A
- ACON N/A
- Revenue Growth
- CNEY 35.10
- ACON N/A
- 52 Week Low
- CNEY $0.26
- ACON $0.03
- 52 Week High
- CNEY $1.98
- ACON $3.85
- Technical
- Relative Strength Index (RSI)
- CNEY 45.18
- ACON 35.37
- Support Level
- CNEY $0.28
- ACON $0.04
- Resistance Level
- CNEY $0.33
- ACON $0.05
- Average True Range (ATR)
- CNEY 0.05
- ACON 0.04
- MACD
- CNEY -0.00
- ACON -0.01
- Stochastic Oscillator
- CNEY 11.15
- ACON 3.47
About CNEY CN Energy Group Inc.
CN Energy Group Inc along with its subsidiaries is a manufacturer and supplier of wood-based activated carbon that is used in pharmaceutical manufacturing, industrial manufacturing, water purification, environmental protection, and food and beverage production and a producer of biomass electricity generated in the process of producing activated carbon. The firm generates a majority of its revenue from Activated carbon.
About ACON Aclarion Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The Company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.